Navigation Links
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
Date:9/18/2009

A federal jury in Tampa Florida returned a verdict in favor of Hako-Med finding that Axiom Worldwide willfully infringed Hako-Med's Horizontal Therapy patent and awarded damages(United States District Court, Middle District of Florida Case No.: 8:06-cv1790-T33AEP). In addition, the federal court issued another permanent injunction against Axiom Worldwide barring all EPS 8000 devices manufactured prior to November 28th 2006.

Honolulu, HI (PRWEB) September 18, 2009 -- A federal jury in Tampa Florida returned a verdict in favor of Hako-Med finding that Axiom Worldwide willfully infringed Hako-Med's Horizontal Therapy patent and awarded damages (United States District Court, Middle District of Florida Case No.: 8:06-cv1790-T33AEP). In addition, the federal court issued another permanent injunction against Axiom Worldwide barring all EPS 8000 devices manufactured prior to November 28th 2006.

A day earlier a federal judge in the United States District Court, Middle District of Florida, Tampa division, the honorable Virginia M. Hernandez Covington, made a temporary injunction against Axiom Worldwide permanent thereby baring Axiom Worldwide from using one of Hako-Med's trademarks.

Axiom Worldwide, based in Tampa Florida, manufactures spinal decompression devices as well as a pain management device, which was found to infringe on Hako-Med's unique patented pain therapy. Axiom Worldwide's head-engineer further admitted under oath that Axiom had done no validation through published clinical studies on their EPS 8000 devices prior to marketing the unsubstantiated claims to physicians that the EPS8000 devices "presents a breakthrough in electrical stimulation therapy" and "the most advanced Electrical Nerve stimulation available today."

Axiom Worldwide has additional pending litigation with other companies, including an alleged trademark infringement suit. (North American Medical vs. Axiom Worldwide No. 1:06-CV-1678-JTC)

Hako-Med offers a special amnesty period from civil litigations for any physician who wants to upgrade from an infringing device to Hako-Med Horizontal Therapy devices by the end of October 2009. (www.hakomed.com)

Hako-Med's policy is to vigorously defend its intellectual property portfolio. Hako-Med is the only manufacturer and supplier of devices with the patented Horizontal Therapy. Horizontal Therapy has been known through many clinical trials to outperform existing treatment methods in the treatment of pain from Osteoarthritis by having immediate as well as longer lasting therapeutic effects without any negative side effects.

For interviews please contact. Kai Hansjurgens president of Hako-Med USA at 1-888-913-7900 www.hakomed.com.

###

Read the full story at http://www.prweb.com/releases/Horizontal_Therapy/Patent_Infringement/prweb2905684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. AXIOM Selects Foresight Corp. for Integration Partnership
2. Axiom Named to Healthcare Informatics Top 100 List
3. Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
4. Global Decompression Announces C.O.D. Available on All Used Axiom DRX 9000 Spinal Decompression Systems
5. WorldatWork Publishes Axiom Consulting Partners' Article on ‘Planning for the New Normal', an Alternative Approach to Compensation Planning
6. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
7. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
8. Global Med Technologies(R) Extends Its Worldwide Outreach
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
11. New USAID grant helps Georgetown meet unmet family planning needs worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
(Date:5/24/2016)... Scotch Plains, NJ (PRWEB) , ... May 24, 2016 , ... ... professional, high quality, patient-oriented dental care. From the moment a patient arrives at ... and Steven Tuckman will work with each and every patient to create a complete ...
(Date:5/24/2016)... ... May 24, 2016 , ... PhysicianOne Urgent Care, advocators in ... tick bites and how to avoid being bitten this spring. , The official ... , Ticks, small spider-like insects, are known for attaching themselves to their prey while ...
(Date:5/24/2016)... CO (PRWEB) , ... May ... ... official announcement of Essette Dashboard, its highly anticipated, web-based software module. The ... platform. The application’s “secret sauce”? Integration with Izenda’s self-service business intelligence solution ...
(Date:5/24/2016)... ... May 24, 2016 , ... NutraPre today announced the ... pregnant women to prevent morning sickness and promote overall heath. Engineered with advanced ... and taste of water. , “Imagine a pregnancy without morning sickness,” NutraPre CEO ...
(Date:5/23/2016)... ... , ... Edward D. Buckingham, M.D . is excited announce that he ... is put out by the National Consumer Advisory Board to honor excellence in medicine. ... for this award. , The National Consumer Advisory Board (NCAB) is a private organization ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Experts from various ... Medicine and the role of technology in innovative ... The First International Conference of VPS-Penn Medicine opened in ... and presence of Sheikh Nahyan bin Mubarak Al Nahyan, Minister ... Medicine, which helps provide personalized medicine and tailor-made healthcare in ...
(Date:5/23/2016)... -- The global  reprocessed medical devices market ... according to a new study by Grand View Research, ... the lack of centralized support for waste disposal in ... for reprocessed medical devices market. Additionally, the long-term cost-efficiency ... the original device is the high impact rendering driver ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
Breaking Medicine Technology: